Hollywood Hairline Treatments: What the Top Hair Regrowth Secrets Mean for Patients

Referenced article: "Hollywood Hairline Secrets: Top Treatments for Hair Regrowth" by Elycia Rubin, The Hollywood Reporter, July 2025.

The Hollywood Reporter recently published a comprehensive feature on the hair regrowth treatments that are reshaping how Hollywood approaches hair loss. The article, written by Elycia Rubin, confirms what physicians practicing advanced regenerative hair medicine have observed for years: the most effective hair restoration results come not from a single treatment, but from a combination of therapies — and, critically, from catching hair loss early before follicles become permanently dormant.

For patients in New York City considering hair restoration, the treatments highlighted in The Hollywood Reporter are not exclusive to celebrities. They are the same evidence-based therapies available at 910 Park Avenue, Manhattan — and the same protocols that form the foundation of the Dr. G Hair Restore approach.

The Treatments Hollywood Is Using for Hair Regrowth

The Hollywood Reporter feature identifies several categories of hair regrowth treatment currently favored by those with access to the most advanced options available. Each represents a distinct mechanism of action — and each plays a specific role in a comprehensive hair restoration protocol.

Platelet-Rich Fibrin (PRF) Therapy

The article highlights platelet-rich fibrin as a cornerstone of modern hair regrowth. PRF is the next generation of PRP (platelet-rich plasma) therapy — and it is what Dr. Golberg exclusively performs at 910 Park Avenue. Where traditional PRP delivers a concentrated burst of growth factors to the scalp, PRF uses a slower centrifuge process to create a fibrin matrix — a scaffold that releases growth factors gradually over days to weeks rather than hours. This sustained release creates a longer regenerative window, giving dormant hair follicles more time to respond to the biological signal.

At 910 Park Avenue, PRF has been a core element of the Restore Protocol since its inception. The difference between PRF and the traditional PRP offered at most clinics in New York City is significant: PRF contains a higher concentration of white blood cells, stem cells, and growth factors, and its slow-release mechanism aligns more effectively with the hair follicle's natural growth cycle. Patients who have tried PRP without meaningful results frequently respond to PRF because the delivery mechanism is fundamentally different — PRF represents where platelet-based hair therapy has evolved.

Exosome Therapy for Hair Loss

The Hollywood Reporter reports that physicians treating celebrity hair loss are seeing remarkable results with exosome therapy — cell-derived nanovesicles that carry growth factors, cytokines, and messenger RNA directly to hair follicle stem cells. Exosomes represent the most advanced non-surgical regenerative technology currently available in hair medicine.

Unlike traditional PRP or PRF, which rely on the patient's own platelet concentration, exosomes introduce an external concentrated signal that instructs dormant follicle stem cells to regenerate. The mechanism is fundamentally different: rather than simply providing growth factors, exosomes deliver the biological instructions that tell stem cells what to do with those growth factors. At 910 Park Avenue, Dr. Golberg pairs exosomes with PRF — the next generation of PRP — for patients with more advanced thinning or longer-duration hair loss, where this amplification is often the difference between modest improvement and meaningful regrowth.

Exosome therapy does not replace platelet-rich fibrin — it amplifies the regenerative signal. The combination of PRF and exosomes creates a synergistic environment that neither therapy achieves alone. This is the foundation of our Restore+ Protocol.

Low-Level Laser Therapy (LLLT)

The feature also identifies low-level laser therapy as a key component of Hollywood's hair regrowth approach. LLLT uses clinically validated wavelengths of light to increase blood flow to the scalp, reduce localized inflammation, and stimulate mitochondrial activity within hair follicle cells. The result is a scalp environment that is more receptive to regenerative treatments and more capable of supporting active hair growth.

Low-level laser therapy is included in every treatment session at 910 Park Avenue — not as an optional add-on, but as an integrated component of the protocol. The laser treatment is administered in conjunction with PRF or PRF-plus-exosome therapy to create optimal scalp conditions at the moment regenerative factors are being delivered to the follicles.

Targeted IV Nutrient Therapy

One of the more notable details in The Hollywood Reporter's coverage is the emphasis on targeted intravenous nutrient therapy as part of combination hair regrowth protocols. This is a significant point, because it acknowledges what diagnostic-first physicians have long understood: hair loss is rarely a purely local problem. It is almost always a systemic condition with nutritional, hormonal, and inflammatory components.

The custom IV formulation at 910 Park Avenue is designed by Dr. Golberg specifically for hair restoration patients, targeting the deficiencies most commonly associated with hair loss — including iron, ferritin, zinc, vitamin D, B12, and biotin. The IV is administered during the treatment session itself, delivering nutrients directly to the bloodstream at therapeutic concentrations that oral supplementation cannot match.

FDA-Approved Hair Loss Medications: Finasteride and Minoxidil

The Hollywood Reporter also discusses the FDA-approved pharmaceutical options for hair loss: finasteride, a prescription medication that blocks the conversion of testosterone to DHT (the hormone most directly responsible for androgenetic hair loss in men), and minoxidil, an over-the-counter topical treatment available for under fifteen dollars that stimulates follicular activity and extends the growth phase of the hair cycle.

Both medications have decades of clinical evidence supporting their efficacy. However, they work through different mechanisms than regenerative therapies like PRF and exosomes. Finasteride addresses the hormonal driver of genetic hair loss; minoxidil increases blood flow to the scalp. Neither addresses nutritional deficiencies, inflammatory markers, thyroid dysfunction, or the other systemic factors that frequently contribute to hair thinning.

This is precisely why a diagnostic-first approach matters. For a patient whose hair loss is primarily driven by DHT, finasteride may be an important part of the solution. For a patient whose thinning is driven by iron deficiency, thyroid dysfunction, or chronic inflammation, finasteride alone will not produce meaningful results. The laboratory blood analysis that begins every protocol at 910 Park Avenue determines which interventions are appropriate for each patient's specific biology.

The PP405 Molecule: What UCLA's Discovery Means

One of the most intriguing developments covered in The Hollywood Reporter is the discovery of PP405 — a molecule identified by researchers at UCLA that appears to awaken dormant hair follicles when applied topically to the scalp. Early studies showed that subjects who applied PP405 at bedtime for one week experienced follicle reactivation in areas that had been dormant.

This is a promising area of research, and it validates a principle that is central to regenerative hair medicine: dormant follicles can be reactivated with the right biological signal. This is the same principle that underlies exosome therapy — delivering molecular instructions that tell dormant stem cells to re-enter the growth cycle.

However, PP405 is still in early research stages and is likely several years from FDA approval and mainstream clinical availability. For patients experiencing hair loss today, the regenerative therapies currently available — PRF, exosomes, LLLT, and targeted IV nutrition — represent the most effective evidence-based options, particularly when guided by proper diagnostic workup.

Why Early Detection Changes Everything

Perhaps the most important insight in The Hollywood Reporter article is the emphasis on early detection. The feature cites physicians who confirm that patients who seek treatment at the first signs of hair thinning achieve significantly better outcomes and require less intensive intervention.

This aligns precisely with the clinical experience at 910 Park Avenue. Hair follicles exist on a spectrum: from fully active (thick, pigmented, growing) to miniaturized (thin, pale, sluggish) to dormant (no longer producing visible hair). Regenerative therapies like PRF and exosomes are most effective when follicles are still active or recently miniaturized. The longer a follicle remains dormant, the more difficult it becomes to reactivate.

This is why the laboratory diagnostic panel is so critical. Many patients present with visible thinning that has been developing for months or years — driven by nutritional deficiencies, hormonal imbalances, or thyroid dysfunction that were never identified. By the time the thinning becomes visible, the underlying biological process may have been active for a significant period. Catching and correcting these factors early — before extensive follicle dormancy occurs — produces dramatically better results.

How These Treatments Come Together in the Dr. G Hair Restore Protocol

What distinguishes the approach at 910 Park Avenue from a clinic that offers any one of these treatments individually is the integration of all of them into a single, diagnostic-driven protocol.

The Restore Protocol — $900 per session

• PRF therapy — platelet-rich fibrin delivering sustained growth factor release to the scalp
• Low-level laser therapy — clinically validated wavelengths to increase scalp blood flow and reduce inflammation
• Custom IV nutrient formulation — physician-designed intravenous infusion targeting hair-loss-specific nutritional deficiencies
• Laboratory blood analysis — comprehensive panel including hormonal markers, thyroid function, nutritional markers, inflammatory markers, and metabolic markers

The Restore+ Protocol — $1,500 per session

Everything in the Restore Protocol, plus exosome therapy — the most advanced non-surgical regenerative technology available for hair restoration. Recommended for patients with more advanced thinning, longer-duration hair loss, or those seeking the most aggressive non-surgical approach.

Both protocols follow a three-session structure spaced four to six weeks apart, aligning treatment timing with the natural phases of the hair growth cycle — anagen (growth), catagen (transition), and telogen (rest). Maintenance sessions once or twice per year protect long-term results.

What New York City Patients Should Take Away

The Hollywood Reporter's coverage reinforces several principles that should guide any patient considering hair restoration treatment in Manhattan or anywhere in New York City:

• Combination therapy outperforms single treatments — the most effective protocols combine PRF, laser therapy, IV nutrition, and (for appropriate candidates) exosome therapy. No single treatment in isolation produces the same results as a coordinated approach
• Early intervention produces better results — patients who begin treatment at the first signs of thinning have more active follicles to work with and typically require fewer sessions to achieve meaningful regrowth
• Diagnosis must come first — the treatments highlighted by The Hollywood Reporter are powerful, but they are only as effective as the diagnostic foundation they rest upon. Without understanding why hair loss is occurring, even the best therapies may be addressing the wrong problem
• Not every clinic offers the same quality of treatment — the difference between a generic PRP injection at a med spa and a comprehensive, diagnostic-first protocol combining PRF (the next generation of PRP), exosomes, LLLT, and IV therapy is significant. Patients should look for practices that investigate before they treat

The treatments The Hollywood Reporter describes are not science fiction and they are not reserved for Hollywood. They are available now, supported by clinical evidence, and — when administered as part of a diagnostic-first protocol — capable of producing meaningful hair regrowth for patients who have been told that nothing can be done.

If you are noticing early signs of hair thinning and would like to understand what is driving it before committing to any treatment, Dr. Golberg's team at 910 Park Avenue, Manhattan is available for a consultation.